ADVERTISEMENT
ADVERTISEMENT
Illustration of bacteriophages infecting a bacterium
Phages Treat Gut Inflammation in Mice
Mixtures of viruses that attack inflammatory bowel disease–causing bacteria in mice also survive the digestive tract and are well-tolerated in humans, a study finds.
Phages Treat Gut Inflammation in Mice
Phages Treat Gut Inflammation in Mice

Mixtures of viruses that attack inflammatory bowel disease–causing bacteria in mice also survive the digestive tract and are well-tolerated in humans, a study finds.

Mixtures of viruses that attack inflammatory bowel disease–causing bacteria in mice also survive the digestive tract and are well-tolerated in humans, a study finds.

Phase I

A wrecking ball destroying a malignant cell as a 3D illustration
Armored CAR T Cells Break Through Immune Suppression in Solid Tumors
Jennifer Zieba, PhD | Sep 26, 2022 | 3 min read
Researchers determined the safety and antitumor ability of genetically engineered CAR T cells that circumvent immune suppression in a prostate cancer phase I clinical trial.
Zika Vaccine Ready for Human Trials
Catherine Offord | Jun 21, 2016 | 1 min read
The US Food and Drug Administration has approved a clinical trial to test the vaccine on healthy adults.
Ebola Vaccine Candidate Shows Promise
Molly Sharlach | Dec 1, 2014 | 2 min read
An experimental Ebola vaccine developed by the US National Institutes of Health appears to be safe and effective, according to a small, early-stage clinical trial.
Geron Sells Stem Cell Assets
Beth Marie Mole | Jan 8, 2013 | 2 min read
BioTime finalizes a deal to buy Geron’s defunct human embryonic stem cell assets.
Parkinson's Vax Enters Clinical Trials
Bob Grant | Jun 7, 2012 | 1 min read
Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
ADVERTISEMENT